BIP
ADPT icon

Bouvel Investment Partners’s Adaptive Biotechnologies ADPT Stock Holding History

Bouvel Investment Partners’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-43,815
Closed -$608K – 85
2026
Q1 		$608K Buy
43,815
+1,297
+3% +$20.7K 0.18% 72
2025
Q4 		$690K Sell
42,518
-360
-0.8% -$5.88K 0.2% 75
2025
Q3 		$641K Buy
42,878
+904
+2% +$11K 0.2% 75
2025
Q2 		$489K Sell
41,974
-1,908
-4% -$17.3K 0.17% 72
2025
Q1 		$225K Buy
43,882
+77
+0.2% +$592 0.08% 77
2024
Q4 		$263K Sell
43,805
-77
-0.2% -$425 0.09% 76
2024
Q3 		$225K Sell
43,882
-1,998
-4% -$8.71K 0.08% 77
2024
Q2 		$166K Sell
45,880
-150
-0.3% -$476 0.06% 77
2024
Q1 		$148K Buy
46,030
+830
+2% +$3.21K 0.06% 75
2023
Q4 		$221K Buy
45,200
+1,001
+2% +$4.57K 0.1% 77
2023
Q3 		$241K Buy
44,199
+376
+0.9% +$2.49K 0.13% 77
2023
Q2 		$294K Buy
43,823
+1,391
+3% +$10.3K 0.16% 71
2023
Q1 		$375K Buy
42,432
+1,240
+3% +$10.9K 0.22% 68
2022
Q4 		$315K Buy
41,192
+1,534
+4% +$11.9K 0.2% 66
2022
Q3 		$282K Buy
39,658
+25,158
+174% +$237K 0.19% 66
2022
Q2 		$117K Buy
14,500
+113
+0.8% +$994 0.09% 66
2022
Q1 		$200K Buy
14,387
+90
+0.6% +$1.42K 0.12% 65
2021
Q4 		$401K Sell
14,297
-173
-1% -$5.3K 0.22% 64
2021
Q3 		$492K Sell
14,470
-241
-2% -$8.72K 0.28% 64
2021
Q2 		$601K Buy
14,711
+75
+0.5% +$2.92K 0.34% 62
2021
Q1 		$589K Sell
14,636
-47
-0.3% -$2.54K 0.38% 59
2020
Q4 		$868K Buy
+14,683
New +$757K 0.62% 57

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bouvel Investment Partners's ADPT Position: Q2 2026 in Review

Bouvel Investment Partners sold out of Adaptive Biotechnologies (ADPT) in Q2 2026, closing a stake of 43,815 shares — an estimated $608K sold.

Bouvel Investment Partners first reported a position in ADPT in Q4 2020 and held it in 22 quarters. The position peaked at $868K in Q4 2020. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Bouvel Investment Partners reported no remaining Adaptive Biotechnologies position as of Q2 2026 after selling out during the quarter.
  • Bouvel Investment Partners sold 43,815 Adaptive Biotechnologies shares in Q2 2026, an estimated $608K.
  • Bouvel Investment Partners first reported a position in Adaptive Biotechnologies in Q4 2020 and held it in 22 quarters.
  • Bouvel Investment Partners's Adaptive Biotechnologies position peaked at $868K in Q4 2020.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Bouvel Investment Partners's 13F filing for Q2 2026, filed 17 Jul 2026.